Epocrates, Inc. (NASDAQ:EPOC)
| CAPS Rating |
|
|---|
EPOC
VS S&P 500 (SPY)
EPOC News and Commentary
- 4 Companies Poised To Control The New Mobile App Economy – SeekingAlpha
- Epocrates Beats on Both Top and Bottom Lines – The Motley Fool
- Is WebMD a Good Stock to Buy Right Now? – Blogs @ The Motley Fool
- Here's How Epocrates May Be Failing You – The Motley Fool
- Epocrates Goes Red – The Motley Fool
- The Next Great Secular Bull Market Is Coming – The Motley Fool
- Centenarians: Health Services Stocks With an Exposure to Future Health Care Trends – The Motley Fool
- Centenarians: Health Services Stocks With Hedge Fund Buying – NASDAQ
- A Simplified ASCO 2011 List for Biotech Investor Research – SeekingAlpha
How do you think EPOC will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
34
Outperform
2
Underperform
All-Star Players
7
Outperform
0
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
